IART logo

Integra LifeSciences Holdings (IART) Shareholders Equity

Annual Shareholders Equity

$1.59 B
-$216.52 M-12.00%

31 December 2023

IART Shareholders Equity Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Shareholders Equity

$1.52 B
-$12.61 M-0.82%

30 September 2024

IART Quarterly Shareholders Equity Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

IART Shareholders Equity Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-12.0%-3.6%
3 y3 years+4.8%-6.8%
5 y5 years+15.4%+9.9%

IART Shareholders Equity High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-12.0%+4.8%-15.7%at low
5 y5 years-12.0%+15.4%-15.7%+13.4%
alltimeall time-12.0%+9025.8%-15.7%+8644.8%

Integra LifeSciences Holdings Shareholders Equity History

DateAnnualQuarterly
Sept 2024
-
$1.52 B(-0.8%)
June 2024
-
$1.53 B(-4.0%)
Mar 2024
-
$1.60 B(+0.6%)
Dec 2023
$1.59 B(-12.0%)
$1.59 B(+0.5%)
Sept 2023
-
$1.58 B(-6.2%)
June 2023
-
$1.68 B(+0.5%)
Mar 2023
-
$1.67 B(-7.2%)
Dec 2022
$1.80 B(+7.1%)
$1.80 B(+4.6%)
Sept 2022
-
$1.72 B(+3.8%)
June 2022
-
$1.66 B(+2.8%)
Mar 2022
-
$1.62 B(-4.1%)
Dec 2021
$1.68 B(+11.2%)
$1.68 B(+3.3%)
Sept 2021
-
$1.63 B(+3.6%)
June 2021
-
$1.57 B(+3.0%)
Mar 2021
-
$1.53 B(+1.0%)
Dec 2020
$1.51 B(+6.9%)
$1.51 B(+8.4%)
Sept 2020
-
$1.40 B(+3.6%)
June 2020
-
$1.35 B(+0.5%)
Mar 2020
-
$1.34 B(-5.3%)
Dec 2019
$1.42 B(+3.0%)
$1.42 B(+2.3%)
Sept 2019
-
$1.38 B(-2.5%)
June 2019
-
$1.42 B(+1.7%)
Mar 2019
-
$1.40 B(+1.5%)
Dec 2018
$1.38 B(+43.0%)
$1.38 B(+0.8%)
Sept 2018
-
$1.37 B(+1.7%)
June 2018
-
$1.34 B(+34.4%)
Mar 2018
-
$998.44 M(+3.8%)
Dec 2017
$962.31 M(+14.6%)
$962.31 M(+5.4%)
Sept 2017
-
$913.12 M(+2.1%)
June 2017
-
$894.55 M(+4.9%)
Mar 2017
-
$852.49 M(+1.5%)
Dec 2016
$839.67 M(+11.7%)
$839.67 M(+2.0%)
Sept 2016
-
$823.43 M(+3.6%)
June 2016
-
$794.79 M(+2.4%)
Mar 2016
-
$776.39 M(+3.3%)
Dec 2015
$751.44 M(+6.7%)
$751.44 M(+2.9%)
Sept 2015
-
$730.10 M(+2.6%)
June 2015
-
$711.72 M(+3.4%)
Mar 2015
-
$688.10 M(-2.3%)
Dec 2014
$704.32 M(+5.7%)
$704.32 M(+2.7%)
Sept 2014
-
$685.98 M(-0.5%)
June 2014
-
$689.23 M(+1.5%)
Mar 2014
-
$679.20 M(+2.0%)
Dec 2013
$666.09 M(+28.6%)
$666.09 M(+33.4%)
Sept 2013
-
$499.48 M(-3.3%)
June 2013
-
$516.59 M(+1.3%)
Mar 2013
-
$509.89 M(-1.5%)
Dec 2012
$517.77 M(+5.1%)
$517.77 M(-1.7%)
Sept 2012
-
$526.70 M(+3.8%)
June 2012
-
$507.21 M(-0.2%)
Mar 2012
-
$508.45 M(+3.2%)
Dec 2011
$492.64 M(-1.5%)
$492.64 M(-1.8%)
Sept 2011
-
$501.52 M(-3.3%)
June 2011
-
$518.82 M(-1.7%)
Mar 2011
-
$527.59 M(+5.5%)
Dec 2010
$499.96 M
$499.96 M(+6.2%)
Sept 2010
-
$470.80 M(+2.3%)
June 2010
-
$460.38 M(+0.5%)
DateAnnualQuarterly
Mar 2010
-
$457.92 M(+2.9%)
Dec 2009
$444.88 M(+19.5%)
$444.88 M(+3.4%)
Sept 2009
-
$430.42 M(+6.9%)
June 2009
-
$402.77 M(+7.6%)
Mar 2009
-
$374.27 M(+0.5%)
Dec 2008
$372.31 M(+43.0%)
$372.31 M(+15.8%)
Sept 2008
-
$321.59 M(-0.8%)
June 2008
-
$324.09 M(+12.2%)
Mar 2008
-
$288.88 M(+10.9%)
Dec 2007
$260.43 M(-12.1%)
$260.43 M(+4.0%)
Sept 2007
-
$250.40 M(+12.0%)
June 2007
-
$223.51 M(-26.8%)
Mar 2007
-
$305.55 M(+3.2%)
Dec 2006
$296.16 M(+2.2%)
$296.16 M(-3.1%)
Sept 2006
-
$305.48 M(-2.1%)
June 2006
-
$312.05 M(+1.0%)
Mar 2006
-
$309.05 M(+6.6%)
Dec 2005
$289.82 M(-5.8%)
$289.82 M(-5.8%)
Sept 2005
-
$307.60 M(+4.4%)
June 2005
-
$294.70 M(-6.3%)
Mar 2005
-
$314.35 M(+2.1%)
Dec 2004
$307.82 M(+14.6%)
$307.82 M(+5.2%)
Sept 2004
-
$292.63 M(+1.5%)
June 2004
-
$288.27 M(+3.7%)
Mar 2004
-
$278.01 M(+3.5%)
Dec 2003
$268.53 M(+8.5%)
$268.53 M(+8.7%)
Sept 2003
-
$247.06 M(+3.8%)
June 2003
-
$238.09 M(+7.5%)
Mar 2003
-
$221.41 M(-10.6%)
Dec 2002
$247.60 M(+21.3%)
$247.60 M(+13.8%)
Sept 2002
-
$217.61 M(+1.1%)
June 2002
-
$215.15 M(+3.2%)
Mar 2002
-
$208.46 M(+2.2%)
Dec 2001
$204.06 M(+279.4%)
$204.06 M(+11.8%)
Sept 2001
-
$182.57 M(+192.0%)
June 2001
-
$62.52 M(+9.9%)
Mar 2001
-
$56.87 M(+5.8%)
Dec 2000
$53.78 M(+41.6%)
$53.78 M(+5.2%)
Sept 2000
-
$51.13 M(+17.7%)
June 2000
-
$43.45 M(-0.1%)
Mar 2000
-
$43.48 M(+14.5%)
Dec 1999
$37.99 M(+21.0%)
$37.99 M(+3.8%)
Sept 1999
-
$36.60 M(-4.2%)
June 1999
-
$38.20 M(-8.4%)
Mar 1999
-
$41.70 M(+32.8%)
Dec 1998
$31.40 M(-12.3%)
$31.40 M(-7.9%)
Sept 1998
-
$34.10 M(+2.4%)
June 1998
-
$33.30 M(+2.8%)
Mar 1998
-
$32.40 M(-9.5%)
Dec 1997
$35.80 M(-22.8%)
$35.80 M(-11.6%)
Sept 1997
-
$40.50 M(-5.6%)
June 1997
-
$42.90 M(-4.2%)
Mar 1997
-
$44.80 M(-3.4%)
Dec 1996
$46.40 M(+166.7%)
$46.40 M(-4.5%)
Sept 1996
-
$48.60 M(-3.8%)
June 1996
-
$50.50 M(-2.7%)
Mar 1996
-
$51.90 M(+198.3%)
Dec 1995
$17.40 M
$17.40 M(-11.2%)
Sept 1995
-
$19.60 M

FAQ

  • What is Integra LifeSciences Holdings annual stockholders equity?
  • What is the all time high annual shareholders equity for Integra LifeSciences Holdings?
  • What is Integra LifeSciences Holdings annual shareholders equity year-on-year change?
  • What is Integra LifeSciences Holdings quarterly stockholders equity?
  • What is the all time high quarterly shareholders equity for Integra LifeSciences Holdings?
  • What is Integra LifeSciences Holdings quarterly shareholders equity year-on-year change?

What is Integra LifeSciences Holdings annual stockholders equity?

The current annual shareholders equity of IART is $1.59 B

What is the all time high annual shareholders equity for Integra LifeSciences Holdings?

Integra LifeSciences Holdings all-time high annual stockholders equity is $1.80 B

What is Integra LifeSciences Holdings annual shareholders equity year-on-year change?

Over the past year, IART annual stockholders equity has changed by -$216.52 M (-12.00%)

What is Integra LifeSciences Holdings quarterly stockholders equity?

The current quarterly shareholders equity of IART is $1.52 B

What is the all time high quarterly shareholders equity for Integra LifeSciences Holdings?

Integra LifeSciences Holdings all-time high quarterly stockholders equity is $1.80 B

What is Integra LifeSciences Holdings quarterly shareholders equity year-on-year change?

Over the past year, IART quarterly stockholders equity has changed by -$57.63 M (-3.65%)